Safety of multiple daily applications of COL-1492, a nonoxynol-9 vaginal gel, among female sex workers. COL-1492 Phase II Study Group.

Van Damme, L; Chandeying, V; Ramjee, G; Rees, H; Sirivongrangson, P; Laga, M; Perriëns, J

Van Damme, L; Chandeying, V; Ramjee, G; Rees, H; Sirivongrangson, P; Laga, M; Perriëns, J.

Affiliation

Van Damme L; Institute of Tropical Medicine, Antwerp, Belgium.

AIDS ; 14(1): 85-8, 2000 Jan 07.

Article in En | MEDLINE | ID: mdl-10714571

Subject(s)

Anti-HIV Agents/adverse effects; Nonoxynol/adverse effects; Administration, Intravaginal; Adult; Anti-HIV Agents/therapeutic use; Colposcopy; Condoms; Female; HIV Infections/prevention & control; Humans; Male; Nonoxynol/therapeutic use; Placebos; Sex Work; Sexually Transmitted Diseases/prevention & control; Vaginal Creams, Foams, and Jellies

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Nonoxynol / Anti-HIV Agents Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Female / Humans / Male Language: En Journal: AIDS Journal subject: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Year: 2000 Type: Article Affiliation country: Belgium

Search on Google

XML

PubMed Links